This guide explains the Massachusetts MPJE as NABP and the Massachusetts Board of Registration in Pharmacy publish it — the exam’s format and Massachusetts’s published passing score, its four competency areas, its fees and attempt rules, the Massachusetts law it is answered under, and the March 2027 blueprint change — and how the PassProfessor program maps onto each part.
Format and scoring
The examination presents 120 multiple-choice questions over 2.5 hours at a Pearson VUE test center: 100 scored questions and 20 unscored pretest questions mixed in indistinguishably. Federal and Massachusetts questions are intermixed with no distinction made between them — you answer each question under the prevailing law of Massachusetts, so where a Massachusetts rule differs from the federal rule, the Massachusetts rule decides. Results are reported pass/fail. Massachusetts publishes the passing standard behind that result: a score of at least 75 on the MPJE under 247 CMR 3.01 — a scaled examination score, not a percentage of correct answers — which is why this program scores practice against a 70% benchmark and labels it as a benchmark. You may attempt the MPJE up to 5 times per jurisdiction, NABP fees run about $270 per attempt, and for Massachusetts the Board of Registration in Pharmacy confirms your eligibility. Massachusetts regulation contains no score-transfer provision, so an MPJE pass earned for another jurisdiction does not carry into Massachusetts licensure.
The four competency areas
NABP’s current MPJE Competency Statements divide the exam into four areas — and the program mirrors that division exactly:
- Licensure and Personnel — 333 practice questions; 22 per full practice exam
- Pharmacist Practice — 498 practice questions; 33 per full practice exam
- Dispensing Requirements — 358 practice questions; 24 per full practice exam
- Pharmacy Operations — 311 practice questions; 21 per full practice exam
The Massachusetts pharmacy law behind the exam
- The Massachusetts questions in this bank are grounded in primary Massachusetts sources read first-hand: the pharmacy practice statutes (Massachusetts General Laws chapter 112, sections 24 through 42D), the Controlled Substances Act (chapter 94C), the Board of Registration in Pharmacy regulations (247 CMR), the Department of Public Health controlled-substance regulations (105 CMR 700.000), the codified fee schedule (801 CMR 4.02), and the 2024 through 2026 session laws. The rulebook has moved recently: chapters 3, 6, 8 and 10 of 247 CMR were amended in 2025, the Shield Law 2.0 changes took effect in November 2025 and January 2026, and the pharmacist prescribing statute was rewritten in 2025. This bank keys on current law throughout, including those changes.
- Massachusetts’s prescription monitoring program rewards careful reading, because the familiar name trap fires here in reverse. The statute — chapter 94C, section 24A — enacts no proper name for the program at all; the operating name, MassPAT, the Massachusetts Prescription Awareness Tool, appears only in the Department of Public Health’s regulations. The Department of Public Health administers the program, not the Board of Registration in Pharmacy. Each pharmacy that delivers a Schedule II, III, IV or V controlled substance — or a designated additional drug — to the ultimate user reports at least once every 24 hours. The look-up duty sits on the prescriber, who must use the program each time a Schedule II or III narcotic or a benzodiazepine is issued; pharmacists carry a program training requirement and must register with MassPAT and maintain a login, but no rule requires a pharmacist to check the program before dispensing. Gabapentin is reported to the program as an additional drug even though it is not a scheduled controlled substance in Massachusetts, and since November 2025 medications for reproductive and gender-affirming health care are excluded from the program unless the Department determines reporting is necessary to protect the public health. Program data are confidential, and law enforcement reaches them only with a probable-cause warrant.
- Massachusetts controlled-substance practice runs on its own numbers. The schedules are established by the Commissioner of Public Health by regulation, and Schedule VI holds every prescription drug outside Schedules I through V. Registration splits by registrant: practitioners register with the Commissioner, while pharmacies and wholesale druggists register with the Board. Electronic prescribing is the baseline for controlled substances, with a closed list of exceptions. A Schedule II prescription becomes invalid thirty days after it is issued; a single filling may run to a ninety-day supply for substance-use-disorder treatment, non-opioid Schedule II and III drugs, and implantable infusion pumps, and to thirty days for everything else in Schedules II and III. The statute sets no expiration ceiling for Schedules III and IV — the six-month, five-refill ceiling exists only for Schedule V, and only as a Board regulation. An adult’s first outpatient opiate prescription, and any opiate prescription for a minor, is capped at a seven-day supply, and Massachusetts sets no morphine-milligram-equivalent threshold anywhere in its codified law. Patients may ask for a partial fill of any Schedule II prescription, with the remainder fillable only by the same pharmacy. And when a Schedule VI prescription has expired or run out of refills and the prescriber cannot be reached, the pharmacist may dispense no more than a fourteen-day supply or the smallest available unit-of-use package — the seventy-two-hour figure sometimes quoted is a MassHealth payment rule, not dispensing authority.
- Substitution in Massachusetts is mandatory, not permissive: unless the practitioner indicates ‘no substitution,’ the pharmacist shall dispense an interchangeable product — an abuse-deterrent product if one exists, otherwise the less expensive reasonably available interchangeable — and the label reads ‘Interchange,’ followed by the name of the product actually dispensed. Interchangeable products come from the Massachusetts List of Interchangeable Drugs: Orange Book A-rated products, plus the Commonwealth’s own Additional List and Exception List. Biological products run the other way — substitution is permitted rather than required, a written patient-specific instruction is what bars it, and the prescriber must be notified within a reasonable time; Massachusetts fixes no day count, and the five-day rule found in other states’ materials is not Massachusetts law. Pharmacy benefit managers are licensed by the Division of Insurance under chapter 176Y, enacted in 2024 — a different subject from the same-day market-review act. Pharmacist scope has widened on verified lines: pharmacists prescribe and dispense hormonal contraceptives and, under the 2025 amendment to section 19F of chapter 94C, medications for HIV and STI treatment and prevention; and qualified pharmacy personnel vaccinate patients age five and older under Department of Public Health policy, though technician trainees may never vaccinate.
- The people rules run on split calendars. The Board of Registration in Pharmacy has thirteen members serving three-year terms, no more than two consecutive. Pharmacists in training complete at least 1,500 internship hours — at least 1,000 of them in a pharmacy setting and at least 500 in clinical-type settings; the older ‘no more than 500’ phrasing in some materials states the opposite of current law. Licensure takes a score of at least 75 on both the NAPLEX and the MPJE, and the two examinations are paired: fail either one and reapplication must come within a year of the original sitting, or both must be retaken. Pharmacy technicians are licensed in Massachusetts, not registered, in three tiers — trainee, technician, and certified pharmacy technician — and one pharmacist may supervise four support staff only on the regulation’s conditions, otherwise three. A manager of record may manage only one pharmacy at a time and must average at least thirty hours a week there. Personal pharmacist licenses expire December 31 of even-numbered years, while pharmacy permits expire December 31 of odd-numbered years. Continuing education is twenty hours every calendar year — at least two in pharmacy law, no more than fifteen by home study, and no carrying hours from one year into the next — and a pharmacist whose license has lapsed by more than two years must pass the MPJE again to restore it. The regulations contain no score-transfer provision: pharmacists licensed elsewhere enter by reciprocity, pass the Massachusetts MPJE, and are not required to retake the NAPLEX.
How the program maps to the exam
The PassProfessor Massachusetts MPJE program carries 1,500 questions across the four competency areas at their published weights. Practice exams draw 100 scored questions in 150 minutes and are scored against a 70% practice benchmark — a target for your preparation, not the MPJE passing standard, because the real result is pass/fail and NABP publishes no raw passing score. Per-topic drills let you work one competency area at a time, and the free sample exam shows the question style before you enroll.
What changes on March 1, 2027
- From March 1, 2027, NABP replaces the MPJE Competency Statements with a new Content Outline — Pharmacy and Pharmacist Practice 30%, Medication Use Process 30%, Regulatory Authority and Legal Obligations 20%, Pharmacy Operations 20%.
- Every question in this bank is dual-tagged to both blueprints, so this program’s practice exams re-weight to the new outline when the change takes effect — the questions you are practicing now stay the right questions.
MPJE scores are not transferable: if you plan to license in more than one MPJE state, plan on that state’s law exam as well. And because every question here is dual-tagged, this program re-weights to the March 2027 outline when it takes effect without the bank changing.